NASDAQ$ILMN

Illumina · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported strong sequential growth driven by sequencing consumable revenue and progress in incorporating genomics into standard of care.

Illumina's third quarter 2020 results showed strong sequential growth with revenue of $794 million, a 26% increase compared to the second quarter of 2020, although a 12% decrease compared to the prior year period. GAAP net income was $179 million, or $1.21 per diluted share, while non-GAAP net income was $150 million, or $1.02 per diluted share.

  • Revenue of $794 million, an increase of 26% compared to the second quarter of 2020 and a 12% decrease compared to $907 million in the prior year period
  • GAAP net income attributable to Illumina stockholders for the quarter of $179 million, or $1.21 per diluted share
  • Non-GAAP net income attributable to Illumina stockholders for the quarter of $150 million, or $1.02 per diluted share
  • Free cash flow of $105 million for the quarter compared to $218 million in the prior year period

Headline financials

Total Revenue

$794M

Previous: $907M-12.5%
EPS (adj)

$1.02

Previous: $1.93-47.2%
Capital Expenditures

-$127M

Previous: -$152M+16.4%
Free Cash Flow

$52M

Previous: $82M-36.6%
Net Income

$179M

Previous: $234M-23.5%
Operating Income

$162M

Previous: $308M-47.4%
Gross Profit

$526M

Previous: $648M-18.8%
Cash & Equivalents

$1.76B

Previous: $1.82B-3.0%
Total Assets

$7.4B

Previous: $7.09B+4.4%
Stock-Based Comp

$61M

Previous: $46M+32.6%

Revenue & EPS history

Illumina · Revenue · Quarterly

$794M

Q3 2020-12.5%vs Q3 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Illumina · $147M total across 1 segment · Q1 2023

  • Service and Other Revenue
    $147M+5.0%

Forward guidance

Illumina has withdrawn its fiscal 2020 full year revenue and earnings per share guidance due to the uncertainties around the severity and duration of the COVID-19 pandemic.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.8%

Avg return

Earnings day

-1.7%

Avg return

5 days after

-0.7%

Avg return

30 days after

35%

22 / 63 earnings

Positive

+21.1%

Q3 2025

Best reaction

-19.1%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.3%+12.5%+28.5%
Q4 2025-10.4%-12.9%-6.7%
Q3 2025+21.1%+23.7%+32.8%
Q1 2025-4.9%-1.7%+3.9%
Q3 2024+3.5%+0.9%-4.8%
Q2 2024+4.9%+7.0%+12.4%
Q1 2024-5.4%-9.5%-16.4%
Q4 2023-3.6%-6.4%-5.3%
Q3 2023-11.1%-11.9%+2.0%
Q2 2023-0.6%-5.9%-14.9%
Q1 2023-7.9%-10.3%-15.5%
Q4 2022-4.9%-5.8%-2.9%
Q3 2022+6.3%+3.3%+3.7%
Q2 2022-8.3%-3.3%-7.5%
Q1 2022-19.1%-28.6%-24.3%
Q4 2021-10.0%-7.0%-17.4%
Q3 2021-2.7%-5.8%-17.2%
Q2 2021-1.5%+0.4%-7.5%
Q1 2021-3.6%-6.6%-2.8%
Q4 2020+12.2%+9.5%-10.0%
Q3 2020-5.5%-4.2%+2.4%
Q2 2020-11.2%-14.9%-14.6%
Q1 2020-3.6%-2.3%+14.4%
Q4 2019-5.8%+2.5%-6.7%
Q3 2019-7.0%-3.5%+1.0%
Q2 2019-0.3%-1.2%-6.4%
Q1 2019-0.2%-0.8%-0.7%
Q4 2018-5.3%-1.7%+8.7%
Q3 2018-8.7%-7.0%-2.3%
Q2 2018+7.7%+10.4%+16.4%
Q1 2018-6.0%-0.6%+10.2%
Q4 2017-3.8%-8.9%-7.1%
Q3 2017-3.2%-0.7%+1.8%
Q2 2017+13.8%+11.9%+17.6%
Q1 2017+2.4%+2.6%-3.6%
Q4 2016+1.4%+1.8%+5.3%
Q3 2016-0.4%-1.1%-6.2%
Q2 2016+7.7%+10.4%+12.5%
Q1 2016-0.7%
Q4 2015-6.0%
Q3 2015-5.0%
Q2 2015-9.4%
Q1 2015-1.6%
Q4 2014-1.9%
Q3 2014+8.9%
Q2 2014-2.6%
Q1 2014+8.8%
Q4 2013+4.6%
Q3 2013+10.6%
Q2 2013+9.1%
Q1 2013+11.3%
Q4 2012-3.6%
Q3 2012-1.1%
Q2 2012-2.7%
Q1 2012-1.9%
Q1 2011-3.5%
Q4 2011-4.1%
Q4 2008-4.1%
Q3 2010+2.2%
Q3 2011+2.2%
Q2 2010+3.6%
Q2 2011+3.6%
Q4 2010+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro